Shenzhen Weiguang Biological Products Co., Ltd. (SHE:002880)
26.62
+0.25 (0.95%)
Jan 23, 2026, 3:04 PM CST
Shenzhen Weiguang Biological Products Company Description
Shenzhen Weiguang Biological Products Co., Ltd. primarily engages in the research, development, production, and sale of blood products in China.
The company offers human factor VIII, human immunoglobulin (PH4), human rabies immunoglobulin, human tetanus immunoglobulin, human hepatitis B immunoglobulin, human albumin, human histaglobulin, human firbrinogen, human immunoglobulin for intravenous injection freeze-dried, lyophilized human rabies vaccine and human prothrombin complex.
Shenzhen Weiguang Biological Products Co., Ltd. was founded in 1985 and is based in Shenzhen, China.
Shenzhen Weiguang Biological Products Co., Ltd.
| Country | China |
| Founded | 1985 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 859 |
| CEO | Caiping Guo |
Contact Details
Address: No. 3402, Guangqiao Avenue Shenzhen, 518107 China | |
| Phone | 86 755 2740 2880 |
| Website | szwg.com |
Stock Details
| Ticker Symbol | 002880 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100002Q58 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Caiping Guo | GM and Director |
| Jianjun Jin | Secretary and Marketing Director |
| Wenjie Xie | Deputy GM and Director |
| Guan Qun Chen | Chief Financial Officer |
| Kui Huang | Accounting Supervisor |